PROTAC ERα Degrader-1 |
Catalog No.GC34341 |
PROTAC ER&알파; Degrader-1은 유비퀴틴 E3 리가제 결합 그룹, 링커 및 단백질 결합 그룹을 포함합니다. PROTAC ER&알파; 특허 WO2017201449A1, 화합물 P1의 분해기-1 추출물. PROTAC ER&알파; 분해자-1은 에스트로겐 수용체-알파(ERα) 분해자입니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2417369-94-7
Sample solution is provided at 25 µL, 10mM.
PROTAC ERα Degrader-1 comprises an ubiquitin E3 ligase binding group, a linker and a protein binding group. PROTAC ERα Degrader-1 extracts from patent WO2017201449A1, compound P1. PROTAC ERα Degrader-1 is an estrogen receptor-alpha (ERα) degrader.
Treatment of the HER2 expressing cells with the PROTAC ERα Degrader-1 (without Ab; compound P1) results in a decreased estrogen receptor-alpha (ERα) levels[1].
[1]. Thomas Pillow, et al. Protac antibody conjugates and methods of use. WO2017201449A1.
Average Rating: 5
(Based on Reviews and 24 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *